These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 33625995)

  • 1. Short chain fatty acids and monocarboxylate transporters in irritable bowel syndrome.
    Fredericks E; Theunissen R; Roux S
    Turk J Gastroenterol; 2020 Dec; 31(12):840-847. PubMed ID: 33625995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered Colonic Bacterial Fermentation as a Potential Pathophysiological Factor in Irritable Bowel Syndrome.
    Ringel-Kulka T; Choi CH; Temas D; Kim A; Maier DM; Scott K; Galanko JA; Ringel Y
    Am J Gastroenterol; 2015 Sep; 110(9):1339-46. PubMed ID: 26303129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short chain fatty acids and colon motility in a mouse model of irritable bowel syndrome.
    Shaidullov IF; Sorokina DM; Sitdikov FG; Hermann A; Abdulkhakov SR; Sitdikova GF
    BMC Gastroenterol; 2021 Jan; 21(1):37. PubMed ID: 33499840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocarboxylate transporter 1 (MCT1) mediates transport of short-chain fatty acids in bovine caecum.
    Kirat D; Kato S
    Exp Physiol; 2006 Sep; 91(5):835-44. PubMed ID: 16857719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of mucosal flora and enterochromaffin cells of the caecum and descending colon in diarrhoea-predominant irritable bowel syndrome.
    Yang J; Wang P; Liu T; Lin L; Li L; Kou G; Zhou R; Li P; Li Y
    BMC Microbiol; 2021 Nov; 21(1):316. PubMed ID: 34773967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in fecal short-chain fatty acids in patients with irritable bowel syndrome: A systematic review and meta-analysis.
    Sun Q; Jia Q; Song L; Duan L
    Medicine (Baltimore); 2019 Feb; 98(7):e14513. PubMed ID: 30762787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocarboxylate transporter 1 (MCT1) plays a direct role in short-chain fatty acids absorption in caprine rumen.
    Kirat D; Masuoka J; Hayashi H; Iwano H; Yokota H; Taniyama H; Kato S
    J Physiol; 2006 Oct; 576(Pt 2):635-47. PubMed ID: 16901943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-based differences in fecal short-chain fatty acid and gut microbiota in irritable bowel syndrome patients.
    Sun QH; Liu ZJ; Zhang L; Wei H; Song LJ; Zhu SW; He MB; Duan LP
    J Dig Dis; 2021 May; 22(5):246-255. PubMed ID: 33822477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The function of the gut microbiota-bile acid-TGR5 axis in diarrhea-predominant irritable bowel syndrome.
    Zhan K; Wu H; Xu Y; Rao K; Zheng H; Qin S; Yang Y; Jia R; Chen W; Huang S
    mSystems; 2024 Mar; 9(3):e0129923. PubMed ID: 38329942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-Chain Fatty Acid Transporters: Role in Colonic Homeostasis.
    Sivaprakasam S; Bhutia YD; Yang S; Ganapathy V
    Compr Physiol; 2017 Dec; 8(1):299-314. PubMed ID: 29357130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel nutrient sensing mechanism underlies substrate-induced regulation of monocarboxylate transporter-1.
    Borthakur A; Priyamvada S; Kumar A; Natarajan AA; Gill RK; Alrefai WA; Dudeja PK
    Am J Physiol Gastrointest Liver Physiol; 2012 Nov; 303(10):G1126-33. PubMed ID: 22982338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiota-Short Chain Fatty Acid Relationships and Microbial Substrate Preferences Vary Across the Spectrum of Irritable Bowel Syndrome (IBS).
    Shin A; Xing Y; Waseem MR; Siwiec R; James-Stevenson T; Rogers N; Bohm M; Wo J; Lockett C; Gupta A; Gupta A; Kadariya J; Toh E; Anderson R; Xu H; Gao X
    medRxiv; 2024 Feb; ():. PubMed ID: 38352442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome.
    Gargari G; Taverniti V; Gardana C; Cremon C; Canducci F; Pagano I; Barbaro MR; Bellacosa L; Castellazzi AM; Valsecchi C; Tagliacarne SC; Bellini M; Bertani L; Gambaccini D; Marchi S; Cicala M; Germanà B; Dal Pont E; Vecchi M; Ogliari C; Fiore W; Stanghellini V; Barbara G; Guglielmetti S
    Environ Microbiol; 2018 Sep; 20(9):3201-3213. PubMed ID: 29749705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between bile acid metabolism and microbiota in irritable bowel syndrome.
    Dior M; Delagrèverie H; Duboc H; Jouet P; Coffin B; Brot L; Humbert L; Trugnan G; Seksik P; Sokol H; Rainteau D; Sabate JM
    Neurogastroenterol Motil; 2016 Sep; 28(9):1330-40. PubMed ID: 27060367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
    Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
    Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic exposure to short-chain fatty acids modulates transport and metabolism of microbiome-derived phenolics in human intestinal cells.
    Van Rymenant E; Abrankó L; Tumova S; Grootaert C; Van Camp J; Williamson G; Kerimi A
    J Nutr Biochem; 2017 Jan; 39():156-168. PubMed ID: 27840292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A diet high in resistant starch modulates microbiota composition, SCFA concentrations, and gene expression in pig intestine.
    Haenen D; Zhang J; Souza da Silva C; Bosch G; van der Meer IM; van Arkel J; van den Borne JJ; Pérez Gutiérrez O; Smidt H; Kemp B; Müller M; Hooiveld GJ
    J Nutr; 2013 Mar; 143(3):274-83. PubMed ID: 23325922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of short-chain fatty acids on the expression of genes involved in short-chain fatty acid transporters and inflammatory response in goat jejunum epithelial cells.
    Zhan K; Jiang M; Gong X; Zhao G
    In Vitro Cell Dev Biol Anim; 2018 Apr; 54(4):311-320. PubMed ID: 29532321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis.
    Liu HN; Wu H; Chen YZ; Chen YJ; Shen XZ; Liu TT
    Dig Liver Dis; 2017 Apr; 49(4):331-337. PubMed ID: 28179092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.
    Wang L; Alammar N; Singh R; Nanavati J; Song Y; Chaudhary R; Mullin GE
    J Acad Nutr Diet; 2020 Apr; 120(4):565-586. PubMed ID: 31473156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.